FDA Commissioner Marty Makary named George Tidmarsh, an accomplished physician-scientist and biotech executive with oncology and pediatrics expertise, as the new director of the Center for Drug Evaluation and Research (CDER). Tidmarsh, with experience leading multiple drug approvals and biotech companies, will bring scientific, regulatory, and operational capabilities to a center currently facing challenges in managing drug reviews and approvals. The appointment has been viewed as a strategic move to stabilize FDA’s drug evaluation processes.